VI Partners

VI Partners is Switzerland’s longest-established venture capital firm focused on early-stage investments in healthcare and technology. They have invested over CHF 350 million across more than 70 startups since 2001. Their healthcare investments span biotech therapeutics (e.g., gene therapy for phagocyte disorders), digital health platforms (e.g., AI-based breast cancer screening), and next-generation drug modalities such as ADCs through their portfolio companies. The firm is backed by leading Swiss corporations and institutions including ETH Zurich, ABB, Nestlé, Credit Suisse, McKinsey & Company among others. They are active investors across Europe with a strong focus on Switzerland.